MTOR and B-cell chronic lymphocytic leukemia: We selected Nfatc1 to explore further its role in the activation of the mTOR pathway and contribution to CLL progression, as alternative splicing of Nfatc1 displayed the highest consistent splicing changes based on P value and absolute percentage spliced-in value among all of these splice variants (Figure 4B).